Donor | Recipient | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sex | Age (years) | Weight (kg) | Height (cm) | Smoker | Cause of death | Sex | Age (years) | Underlying disease | CMARS | Type of Tx | Maintenance therapy |
F | 35 | 80 | 170 | Yes | Cerebral haemorrhage | M | 50 | IPF | 0 | D | Ciclosporin-MMF-Prednisolon |
F | 34 | 57 | 174 | No | Other | M | 58 | IPF | 0.11 | D | Tacrolimus-Azathioprin-Prednisolon |
F | 52 | 70 | 170 | No | Trauma | M | 55 | IPF | 0.33 | D | Tacrolimus-Azathioprin-Prednisolon |
F | 58 | 73 | 170 | No | Cerebral haemorrhage | M | 58 | Sarcoidosis | 0 | D | Ciclosporin-MMF-Prednisolon |
F | 47 | 65 | 170 | No | Cerebral haemorrhage | M | 59 | IPF | 0.43 | D | Tacrolimus-Everolimus-MMF- Prednisolon |
F | 37 | 75 | 170 | ND | Trauma | M | 43 | Sarcoidosis | 0.375 | D | Ciclosporin-MMF-Prednisolon |
M | 19 | 75 | 180 | ND | Trauma | F | 49 | A1ATD | 0.285 | D | Tacrolimus-MMF-Prednisolon |
M | 54 | 62 | 172 | Yes | Cerebral haemorrhage | F | 41 | Emphysema | 0.36 | S | Ciclosporin-MMF-Prednisolon |
F | 33 | 65 | 170 | ND | Other | M | 60 | IPF | 0.375 | D | Ciclosporin-MMF-Prednisolon |
M | 45 | 85 | 175 | ND | Cerebral haemorrhage | F | 56 | Emphysema | 0.428 | S | Ciclosporin-MMF-Prednisolon |
A1ATD, α-1-antitrypsin deficit; CMARS, cumulative mean average rejection score; D, double; F, female; IPF, idiopathic pulmonary fibrosis; M, male; MMF, mycophenolate mofetil; ND, not determined; S, single; Tx, transplantation.